299. Peptide Therapy: Are Peptides Signal or Noise for CEOs and High Performers?

Executive Health and Life28mApril 8, 2026

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “299. Peptide Therapy: Are Peptides Signal or Noise for CEOs and High Performers?” inside PodZeus.

AI-Generated Summary

In this episode of Executive Health and Life, host Julian Hayes II tackles the growing interest in peptide therapy among high-performing executives and entrepreneurs. He addresses the core question: are peptides a legitimate tool for performance optimization or just another trend? Hayes emphasizes that peptides are not magic solutions but rather signaling molecules that amplify existing biological processes. He argues that their value depends entirely on context—particularly a strong foundational health baseline. Drawing from personal experience, including using VPC-157 to manage stress-induced gastrointestinal issues, Hayes illustrates how peptides can support recovery and resilience when used deliberately. He warns against chasing trends without proper data, foundational habits, or professional guidance, stressing that 'boring is beautiful' when it comes to health systems. The episode underscores the importance of baseline biomarker testing, intentional sequencing, and risk tolerance before introducing any biohacking tool.

Key Takeaways
1

Peptides are signaling molecules, not magic bullets—they amplify existing biological processes.

2

A strong foundational health system (sleep, nutrition, stress management) is essential before considering peptides.

3

Baseline biomarker testing is critical to measure progress and avoid false conclusions.

4

Peptides should be used with intention, precision, and data—not as a trend or shortcut.

5

The quality and sourcing of peptides vary widely; COAs and trusted providers are crucial.

…and 3 more takeaways available in PodZeus

Chapters
0:00
3 min

The Rise of Peptide Interest Among High Performers

Julian Hayes introduces the growing curiosity around peptide therapy among CEOs and founders, framing it as a serious question from people who can't afford biological noise or inefficiency.

3:00
5 min

What Are Peptides and Why Are They Gaining Traction?

Hayes explains peptides as short chains of amino acids that act as signaling molecules. He traces their evolution from medical use to mainstream biohacking, highlighting accessibility and targeted applications.

8:00
7 min

Peptides as Tools, Not Fixes: The Foundation First Principle

With a poor baseline, things like peptides are going to amplify the chaotic environment that you're throwing them into. With a stronger baseline, a steady baseline, these can amplify what you already have there.

Highlight
15:00
7 min

Quality, Access, and the Gray Market of Peptides

Nothing is absolute. But if you think about that, this also applies to the supplements that people have been buying for years on Amazon.

Highlight
22:00
6 min

Who Should Consider Peptides? The High-Performance Context

When you're performing at a high level, the margins most certainly do matter.

Highlight
High-Impact Quotes
With a poor baseline, things like peptides are going to amplify the chaotic environment that you're throwing them into. With a stronger baseline, a steady baseline, these can amplify what you already have there.
Julian Hayes II16:58
Viral: 85.0
When you're performing at a high level, the margins most certainly do matter.
Julian Hayes II26:24
Viral: 80.0
Peptides are far from being something that's magic. It's much more than that. They're tools.
Julian Hayes II26:34
Viral: 75.0
Speakers

Host

Julian Hayes II
Topics Discussed
peptide therapy95%high-performance health90%biological foundation88%baseline biomarkers87%health optimization85%recovery and resilience80%biohacking75%quality and sourcing of supplements70%
People & Brands

Julian Hayes II

person

12xPositive

VPC-157

other

4xPositive

peptide bioregulators

other

3xNeutral

Retatrutide

product

2xNeutral

BPC-157

other

2xNeutral

Function Health

organization

2xPositive

TB-500

other

2xNeutral

GLP-1 agonist

product

2xNeutral

Self Mastery

other

1xPositive

Eli Lilly

organization

1xNeutral

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “299. Peptide Therapy: Are Peptides Signal or Noise for CEOs and High Performers?” inside PodZeus.

Start discovering podcast insights today

Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.

No credit card required • 7-day trial • Cancel anytime